A new study suggests that people with Alzheimer’s on the drug risperidone, an antipsychotic drug often prescribed as the brand name Risperdal, may be better off continuing to take the drug if they have not experienced negative side effects.
Because of the potential side effects, risperidone is only recommended to be prescribed for three to six months. After that point, a written explanation is required to continue the drug. A study, published in the New England Journal of Medicine and funded by the National Institutes of Health, investigated the effects of discontinuing the medication among individuals who had seen improvements as a result of the drug. Researchers prescribed risperidone to individuals with Alzheimer’s disease who showed signs of agitation and aggression. After 16 weeks, researchers put half of the individuals who did well on the drug on a placebo. The other half continued the treatment. The study found that those on the placebo were twice as likely to have their symptoms return. The rate of side effects and death were equal among the two groups.
Researchers warned that antipsychotics can carry the risk of serious side effects and should not be used on all individuals with Alzheimer’s disease, but discontinuing medication that has achieved benefits is not always the right choice. "One must be cautious about discontinuing the medication,” said study author Dr. D.P. Devanand, director of the division of geriatric psychiatry at Columbia Psychiatry and the New York State Psychiatric Institute in New York City. “If a person does well on it and there are not too many side effects, maybe they should stay on it for a while and be monitored closely."
For more information, read the article: Some With Alzheimer's Better Off Staying on Antipsychotics: Study Or, read the full study: Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease.
Business Planning, Dining, Memory Care Best Practices and Research, Memory Care Education, Property Management, Value-Added Amenities and Services
As Alzheimer’s becomes more prevalent among the nation’s older adults, senior living communities are creating innovative ways to create nurturing envi...
Falls Prevention, Managed Risk
The Administration on Aging, part of the federal government’s Administration for Community Living, announced the award of $4 million in new grants to ...
Accessiblity Issues, Disabilities, Managed Risk, Risk Management
The Justice Department has issued additional guidance on the use of service animals in relation to the Americans with Disabilities Act. The guidanc...
All About Alzheimer’s: A Look at Tests, Ethnicities, Diabetes, Drugs and Dementia-Friendly Communities
Facts and Figures, Health and Wellness, Memory Care Best Practices and Research, Memory Care Education, Reports
Errors on memory and thinking tests could signal Alzheimer’s disease up to 18 years before diagnosis, according to a new study from Rush University re...
cheatsheet, Family Relations, Health and Wellness, Memory Care Best Practices and Research, Memory Care Education, Partnerships
ALFA is partnering with US Against Alzheimer’s to support Dementia Friendly America, a new national initiative to build a more dementia-friendly natio...
Clinical Quality and Quality Care Delivery, Managed Risk, Medication Management
The Society for Post-Acute and Long-Term Care will be leading a three-year $1.5 million national trial to examine methods to reduce unnecessary use of...
ALFA Conference & Expo, ALFA Events, Business Planning, CEO, cheatsheet, Clinical Quality and Quality Care Delivery, Dining, Engage, Executive Talent Management, Finance, Human Resources, Marketing Strategy, Partnerships, Property Management, Risk Management, Sales Process, Staffing, Staffing & Performance, Strategy
ALFA convenes Executive Roundtables several times a year, which are made up of industry peers from different companies working in the same field. Thes...
Elder Abuse, Hearings, Medication Management, Memory Care Best Practices and Research, Memory Care Education
A top lawmaker on the Senate Special Committee on Aging has launched an examination of products, regulations and retailers in the dietary supplement i...
Business Planning, Featured Magazine Articles, Health and Wellness, Memory Care Best Practices and Research, Memory Care Education, Wellness Program
Providers leverage the latest research on physical exercise, sensory inputs, and more to provide better resident care and delay the onset of Alzheimer...
Engage, Memory Care Best Practices and Research, Memory Care Education
Hearthstone’s founder, John Zeisel, is broadcasting a new show on a local Massachusetts cable station called “Hopeful Aging with Dr. John Zeisel.” The...